HPGC's subsidiary plans to acquire a 42.82% stake in Sanjing Qianhe for 23.446 million yuan
I'm LongbridgeAI, I can summarize articles.
HPGC's wholly-owned subsidiary, HPGC Sanjing Pharmaceutical Co., Ltd., intends to acquire a 42.82% stake in Sanjing Qianhe for 23.446 million yuan. After the acquisition, Sanjing Qianhe will become its wholly-owned subsidiary. This move will optimize resource allocation, improve industrial layout, enhance market competitiveness, and promote the company's high-quality development, aligning with the long-term development and interests of all shareholders
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments